rawfin.tv
STAAR Surgical Reports Q2 2026 Profit Rebound with $8.1M Net Income, $93.5M Sales
Earningsstocks🟠 Score 8AI Generated

STAAR Surgical Reports Q2 2026 Profit Rebound with $8.1M Net Income, $93.5M Sales

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

STAAR Surgical (STAA) announced a strong return to profitability in Q2 2026, reporting $8.1 million in net income on $93.5 million in sales. Despite the positive financial results, the stock price reaction was muted, with the company's performance heavily influenced by the Chinese market.

STAAR SurgicalEarningsNet IncomeSalesChina MarketMedical DevicesQ2 Results

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks